BioSpace News Archive

Pharm Country

Matinas BioPharma to Participate in Panel Discussion During Maxim Group Infectious Disease Virtual Conference

Matinas BioPharma Holdings, Inc., announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to participate in a panel discussion, as well as host investor meetings, during the Maxim Group Infectious Disease Virtual Conference..

April 28, 2020
·
4 min read
Drug Development

Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor

VOYAGER did not meet the primary endpoint of an improvement in progression-free survival for avapritinib versus regorafenib in patients with third- or fourth-line GIST

April 28, 2020
·
10 min read
Deals

BD Board Declares Dividend payable on June 30, 2020

The Board of Directors of BD has declared a quarterly dividend of $0.79 per common share, payable on June 30, 2020 to holders of record on June 9, 2020.

April 28, 2020
·
1 min read
Business

Gemini Therapeutics Appoints David Lubner as Independent Director

Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for dry Age-related Macular Degeneration and linked ocular disorders, announced that David Lubner has been appointed to serve as an independent member of its Board of Directors.

April 28, 2020
·
2 min read
Pharm Country

Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy

Part 2 of pivotal study met its primary endpoint by demonstrating unsupported sitting in infants aged 1-7 months with type 1 SMA after 12 months of treatment

April 28, 2020
·
10 min read
Deals

BioInvent Interim Report January 1 - March 31, 2020

Promising progress reported for BI-1206 in combination with rituximab

April 28, 2020
·
6 min read
Deals

Trialbee Secures €11 million in Funding to Scale Digital Patient Trial Recruitment and Engagement Solutions

Investment led by MTIP enables the company to expand its product development to meet the growing demand for patient-centric technology solutions in clinical trials

April 28, 2020
·
4 min read
BioMidwest

BriteLife Recovery Is Now LegitScript Certified

BriteLife Recovery is excited to announce that they are now LegitScript Certified and found to comply with LegitScript’s certification standards

April 28, 2020
·
3 min read
Business

Centene Corporation Reports First Quarter 2020 Results

Centene Corporation announced its financial results for the first quarter ended March 31, 2020, reporting diluted earnings per share of $0.08 and Adjusted Diluted EPS of $0.86.

April 28, 2020
·
35 min read
Business

Theravance Biopharma to Report First Quarter 2020 Financial Results on May 6, 2020

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its first quarter 2020 financial results and provide a business update after market close on Wednesday, May 6, 2020.

April 28, 2020
·
2 min read